Entrada Therapeutics Inc. (TRDA)
NASDAQ · Healthcare
Entrada Therapeutics Inc. Cash on Hand 2023–2025
Entrada Therapeutics Inc. annual/quarterly cash on hand history from 2023 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Entrada Therapeutics Inc. cash on hand for the quarter ending December 31, 2025 were 90.4M, a 10.69% decrease year-over-year.
- Entrada Therapeutics Inc. cash on hand for 2025 were 90.4M, a 10.69% decrease from 2024.
- Entrada Therapeutics Inc. cash on hand for 2024 were 101.2M, a 49.72% increase from 2023.
- Entrada Therapeutics Inc. cash on hand for 2023 were 67.6M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Entrada Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $90 |
| 2024 | $101 |
| 2023 | $68 |
| Entrada Therapeutics Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $90 |
| 2024-12-31 | $101 |
| 2023-12-31 | $68 |
Entrada Therapeutics Inc. Cash on Hand — FAQ
Entrada Therapeutics Inc. (TRDA) cash on hand over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TRDA's cash on hand history?
The chart and table above show Entrada Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.